Skip to content

Alto Neuroscience ANRO Prepaid expenses

Prepaid expenses at other companies

Stryker logo
StrykerSYK
$1.38B-10.6%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Arrowhead Research logo
Arrowhead ResearchARWR
IAR
Integra LifeSciencesIART
Lantheus Holdings logo
Lantheus HoldingsLNTH

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's prepaid expenses?
Alto Neuroscience (ANRO) reported prepaid expenses of $3.47M in Q1 2026.
How has Alto Neuroscience's prepaid expenses changed year-over-year?
Alto Neuroscience's prepaid expenses increased by 308.7% year-over-year, from $849K to $3.47M.
What is the long-term trend for Alto Neuroscience's prepaid expenses?
Over 2 years (2023 to 2025), Alto Neuroscience's prepaid expenses has grown at a 41.4% compound annual growth rate (CAGR), from $522K to $1.04M.